The Patent Finder

Terms ending in 2029

Genentech, Inc.

Every in-force patent on Genentech, Inc.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 7,910,098Anti-VEGF Antibodies
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 8,329,7095H-CYCLOPENTA[D]PYRIMIDINES as Akt Protein Kinase Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 9,328,0915H-CYCLOPENTA[d]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 9,365,642Methods and Compositions for Targeting Polyubiquitin
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 9,492,553Nemorubicin Metabolite and Analog Reagents, Antibody-Drug Conjugates and Methods
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 8,436,147Antibodies and Immunoconjugates and Uses Therefor
In force
 · High confidence
Genentech, Inc.In forceHigh confidence
US 11,597,776Composition Comprising Antibody That Binds to Domain II of HER2 and Acidic Variants Thereof
In force
 · Low confidence
Genentech, Inc.In forceLow confidence
US 12,110,341Composition Comprising Antibody That Binds to Domain II of HER2 and Acidic Variants Thereof
In force
 · Low confidence
Genentech, Inc.In forceLow confidence
US 8,303,955Humanized ANTI-CD40 Antibodies and Their Methods of Use
In force
 · High confidence
Seagen Inc.In forceHigh confidence
US 7,846,929Phosphoinositide 3-Kinase Inhibitor Compounds and Methods of Use
In force
 · High confidence
F. Hoffmann-La Roche AGIn forceHigh confidence
36 more term ends in 2029 · Pro
10 of 46 patents shown. Soonest term end first, then patent number.
Pro members see all 46.
Upgrade to Pro
34 of these are in force and held by Genentech, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited